Subscribe
shutterstock_685347493_katherine_welles
Katherine Welles / Shutterstock.com
3 September 2020GenericsRory O'Neill

Sigmapharm to appeal Pfizer and BMS’ Eliquis win

Generics maker  Sigmapharm Laboratories is appealing against a court win for  Pfizer and  Bristol Myers Squibb (BMS) over patents for blood-thinner  Eliquis (apixaban).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
BMS to acquire Forbius in oncology expansion
27 August 2020   Bristol Myers Squibb has announced a deal to acquire protein engineering company Forbius, including its portfolio of protein inhibitors.
Americas
BMS, Pfizer secure victory over generic makers
7 August 2020   In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
BMS to acquire Forbius in oncology expansion
27 August 2020   Bristol Myers Squibb has announced a deal to acquire protein engineering company Forbius, including its portfolio of protein inhibitors.
Americas
BMS, Pfizer secure victory over generic makers
7 August 2020   In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis.

More on this story

Americas
BMS to acquire Forbius in oncology expansion
27 August 2020   Bristol Myers Squibb has announced a deal to acquire protein engineering company Forbius, including its portfolio of protein inhibitors.
Americas
BMS, Pfizer secure victory over generic makers
7 August 2020   In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis.

More features

WilmerHale gains partner with ‘deep expertise’
UKIPO rejects Boehringer’s SPC for horse inhaler
Bayer, Orion take on Indian generic over $117bn drug
‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company